Related Experiment Video
Updated: Jan 15, 2026
Combination Radiotherapy in an Orthotopic Mouse Brain Tumor Model
Published on: March 6, 2012
Radiobiology and Radioresistance in High-Dose Radiosurgery for Brain Tumors: A Hypothesis-Generating Study Using an
Anastasia Janas1, Carolin Senger2, Kiril Krantchev1
1Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt Universität zu Berlin, Department of Neurosurgery, Charitéplatz 1, 10117 Berlin, Germany; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt- Universität zu Berlin, Department of Radiation Oncology and Radiotherapy, Augustenburger Platz 1, 13353 Berlin, Germany.
High-dose stereotactic radiosurgery (SRS) effectively controls brain tumors by modulating tumor-associated macrophages (TAMs). Dose-dependent responses reveal insights into hypoxia and immune signaling, crucial for long-term tumor control.
Area of Science:
- Neurosurgery
- Oncology
- Immunology
Background:
- Stereotactic radiosurgery (SRS) is a key noninvasive treatment for brain tumors.
- The radiobiological mechanisms driving SRS efficacy, particularly long-term tumor response, require further elucidation.
- Tumor-associated macrophages (TAMs) are critical regulators of the tumor microenvironment and immune responses.
Purpose of the Study:
- To investigate the long-term, dose-dependent effects of high-dose SRS on a murine glioma model.
- To explore the role of TAMs in mediating tumor response and immune modulation following SRS.
- To identify radiobiological mechanisms underlying treatment resistance and efficacy.
Main Methods:
- Utilized the intracranial GL261-glioma mouse model, administering single-dose SRS at 20 Gy or 40 Gy.
- Longitudinal tumor response was monitored using 7T MRI, with histological and flow cytometry analyses performed at multiple timepoints.
- Evaluated parameters included cell proliferation, apoptosis, vascular morphology, blood-brain/tumor-barrier integrity, hypoxia, TAM recruitment and polarization, and immune cell populations.
Main Results:
- SRS efficacy demonstrated a dose-dependent effect, with 40 Gy suppressing tumor growth more effectively than 20 Gy.
- Nonresponders to SRS showed increased hypoxia and CXCR4 expression, correlating with TAM recruitment patterns.
- Responders exhibited characteristics of vascular normalization and a higher M1/M2 TAM ratio, indicating an anti-tumor immune response.
Conclusions:
- Long-term tumor control following SRS is significantly influenced by the dynamic role of TAMs.
- Hypoxia and CXCL12/CXCR4 signaling are associated with SRS treatment resistance.
- Findings suggest potential SRS-induced vascular normalization and provide a framework for optimizing combination strategies.
More Related Videos
10:52Stereotactic Intracranial Implantation and In vivo Bioluminescent Imaging of Tumor Xenografts in a Mouse Model System of Glioblastoma Multiforme
Published on: September 25, 2012
10:48PET and MRI Guided Irradiation of a Glioblastoma Rat Model Using a Micro-irradiator
Published on: December 28, 2017